Results
74,735 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Campbell Renee LSVP, Capital Markets & Risk |  VMIVALMONT INDUSTRIES INCOption exercise | M | — 838 sh | Aug 19, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Campbell Renee LSVP, Capital Markets & Risk | VMIVALMONT INDUSTRIES INC Option exercise | M | — 838 sh | Aug 19, 2026 |
| 5 | Cieri MichaelChief Product Officer |  BILLBILL Holdings, Inc.Grant or award | A | — 19.6K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 5 | Britt Christopher RDirector, Chief Executive Officer |  CHYMChime Financial, Inc.Gift | G | — 11.4K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 5 | Parks Louis A.Director |  STRRStar Equity Holdings, Inc.Option exercise | M | — 485 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 5 | Palmer JenniferDirector | STRRStar Equity Holdings, Inc. Option exercise | M | — 460 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 4 | Hohl BenjaminCHIEF FINANCIAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $82K 1,388 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 4 | Wetterwald JulienChief Technology Officer |  WLTHWEALTHFRONT CORPOpen-market sale · 10b5-1 plan | SELL | $140K 15.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 3 | Song EstherSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $17K 164 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 3 | Song EstherSee Remarks | SYNASYNAPTICS Inc Open-market sale · 10b5-1 plan | SELL | $9,941 96 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 3 | Song EstherSee Remarks | SYNASYNAPTICS Inc Open-market sale · 10b5-1 plan | SELL | $18K 177 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 2 | Foff Erin PennockChief Medical Officer |  MPLTMapLight Therapeutics, Inc.Grant or award | A | — 54.2K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 2 | Fruhbeis Todd MichaelDirector | STRRStar Equity Holdings, Inc. Option exercise | M | — 535 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 2 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Grant or award | A | — 13.4K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 1 | Starzak Alissa MichelleChief Legal Officer |  NETCloudflare, Inc.Option exercise · 10b5-1 plan | M | $259K 3,333 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 1 | Herrington Douglas JCEO Worldwide Amazon Stores |  AMZNAMAZON COM INCOption exercise · 10b5-1 plan | M | — 9,352 sh | Aug 19, 2026 traded Aug 15, 2026 |
| 1 | Kereere SuzanPresident, Global Markets |  PYPLPayPal Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $49K 800 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 1 | Dasdan AliChief Technology Officer |  DBXDROPBOX, INC.Tax withholding · 10b5-1 plan | F | $663K 19.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 15.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Riley JanelChief Accounting Officer | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | $113K 1,667 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer |  SMRNUSCALE POWER CorpOption exercise · 10b5-1 plan | M | $0 0 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER |  GPCRStructure Therapeutics Inc.Option exercise · 10b5-1 plan | M | $4,018 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 34.6K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Derivative conversion · 10b5-1 plan | C | — 3,939 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Ellenbogen MichaelDirector |  EVLVEvolv Technologies Holdings, Inc.Option exercise · 10b5-1 plan | M | — 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Starzak Alissa MichelleChief Legal Officer | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | — 3,333 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $28K 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Song EstherSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 4,711 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer | SMRNUSCALE POWER Corp Option exercise · 10b5-1 plan | M | — 20.0K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 31.0K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $13K 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Derivative conversion · 10b5-1 plan | C | — 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Ellenbogen MichaelDirector | EVLVEvolv Technologies Holdings, Inc. Option exercise · 10b5-1 plan | M | $19K 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Riley JanelChief Accounting Officer | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | — 1,667 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Song EstherSee Remarks | SYNASYNAPTICS Inc Tax withholding · 10b5-1 plan | F | $107K 972 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 37.9K sh | Aug 19, 2026 traded Aug 17, 2026 |